18.2.2026 07:00:00 CET | Thor Medical ASA | Non-regulatory press releases
Thor Medical ASA will publish its second-half and full-year 2025 results on
Thursday, February 26, 2026, at 07:00 CET.
The company will host a presentation of the results at 08:00 CET the same day at
Sjølyst Møtesenter, Drammensveien 165, Oslo. Investors, analysts and media are
invited to attend.
Date: Thursday, February 26, 2026
Time: 08:00 CET
Venue: Sjølyst Møtesenter, Drammensveien 165, Oslo
Webcast: https://qcnl.tv/p/oaKSlZtoFMGAjpGTZIKcdg -
https://nor01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fqcnl.tv%2Fp%2F
oaKSlZtoFMGAjpGTZIKcdg&data=05%7C02%7C%7C49a6bd5b0d794cb377a508de6d35f2a7%7C18d5
60945f654afda565a84b07f106b0%7C0%7C0%7C639068275629967674%7CUnknown%7CTWFpbGZsb3
d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIl
dUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=gUG3dfimV2zYzWSKJrOMryzhJUeZE17BHqoelQNqYs4%3D
&reserved=0
The interim financial report for the second half and full year of 2025, and
presentation material, will be released at 07:00 CET and made available on
www.thormedical.com - http://www.thormedical.com
CONTACTS
Mathias Nilsen Reierth, Head of Communications and Corporate Affairs, Thor
Medical ASA, +47 988 05 724, mathias.reierth@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of alpha particle emitters produced from
naturally occurring thorium. Its proprietary production process requires no
irradiation or use of nuclear reactors, and provides reliable, environmentally
friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical
industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit
www.thormedical.com - http://www.thormedical.com.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18808516/6798/Download%20announce
ment%20as%20PDF.pdf